SUBSCRIBERS
Abbott taps better sentiment to fund purchase of St Jude
Published Fri, Nov 18, 2016 · 09:50 PM
New York
ABBOTT Laboratories took advantage of a post-election rally in healthcare debt to announce a US$15.1 billion bond on Thurs-day as it sought to fund its US$25 billion acquisition of rival St Jude Medical.
Changing sentiment towards healthcare companies following Donald Trump's surprise electoral victory was seen benefiting the medical device maker, which has been struggling to carry out its aggressive expansion plans.
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Companies & Markets
Stocks to watch: DBS, Olam, Parkway Life Reit, Japfa, CSE Global
Mastercard’s profit beats as consumer spending defies inflation worries
Google’s payments to Apple reached US$20 billion in 2022, antitrust court documents show
DBS Q1 profit up 15% to S$2.96 billion; interim dividend at S$0.54
Qualcomm forecast beats estimates as AI drives chip sales in China
eBay forecasts Q2 revenue below estimates as consumer spending remains strained